摘要
目的 对反流性胃炎患者采取多潘立酮药物治疗后的临床疗效展开研究.方法 本研究选择2018年12月-2019年12月我院54例反流性胃炎患者,根据随机数字表法分组,27例常规治疗(对照组),27例多潘立酮治疗(研究组),比较疗效.结果 研究组各项症状积分较对照组低;研究组治疗有效率高于对照组;研究组患者平均反流次数低于对照组,返流时间短于对照组;研究组中不良反应低于对照组,差异有统计学意义(P<0.05).结论 对反流性胃炎患者采取多潘立酮药物治疗可以积极有效的改善临床症状.
Objective To investigate the clinical efficacy of domperidone in patients with reflux gastritis. Methods A total of 54 patients with reflux gastritis treated in our hospital from December 2018 to December 2019 were selected.They were randomly divided into the control group(n=27,routine treatments)and the study group(n=27,domperidone)according to the random number table method.The efficacy was compared between the two groups. Results The symptom scores of the study group were lower than those of the control group;The treatment efficiency of the study group was higher than that of the control group;The average number of reflux in the study group was lower than that in the control group,and the reflux time was shorter than that in the control group;The incidence of adverse reactions was lower than that in the control group,and the differences were statistically significant(P < 0.05). Conclusion For patients with reflux gastritis,domperidone can positively and effectively improve clinical symptoms.
作者
薛媛
段瑞丽
张维金
XUE Yuan;DUAN Ruili;ZHANG Weijin(The Third Outpatient Department,No.988 Hospital of the Joint Logistics Support Force,Henan,Zhengzhou 450000,China)
出处
《中国医药科学》
2020年第14期79-81,共3页
China Medicine And Pharmacy
关键词
反流性胃炎
多潘立酮
不良反应
Reflux gastritis
Domperidone
Adverse reactions.
